EMDB/PDB/SASBDBから引用されている文献のデータベース

キーワード
構造解析手法	All X線回折 NMR 電子顕微鏡小角散乱中性子線回折線維回折粉末回折赤外分光 EPR FRET 理論モデルハイブリッド
著者・登録者
ジャーナル
IF	>30 >20 >10 >5 all

タイトル	Single atom changes in newly synthesized HIV protease inhibitors reveal structural basis for extreme affinity, high genetic barrier, and adaptation to the HIV protease plasticity.
ジャーナル・号・ページ	Sci Rep, Vol. 10, Page 10664-10664, Year 2020
掲載日	2019年4月2日 (構造データの登録日)
著者	Bulut, H. / Hattori, S.I. / Aoki-Ogata, H. / Hayashi, H. / Das, D. / Aoki, M. / Davis, D.A. / Rao, K.V. / Nyalapatla, P.R. / Ghosh, A.K. / Mitsuya, H.
リンク	Sci Rep / PubMed:32606378
手法	X線回折
解像度	1.21 - 1.54 Å
構造データ	PDB-6ogl: X-ray crystal structure of darunavir-resistant HIV-1 protease (P51) in complex with GRL-003 手法: X-RAY DIFFRACTION / 解像度: 1.21 Å PDB-6ogp: X-ray crystal structure of wild type HIV-1 protease in complex with GRL-063 手法: X-RAY DIFFRACTION / 解像度: 1.53 Å PDB-6ogq: X-ray crystal structure of darunavir-resistant HIV-1 protease (P30) in complex with GRL-003 手法: X-RAY DIFFRACTION / 解像度: 1.41 Å PDB-6ogs: X-ray crystal structure of darunavir-resistant HIV-1 protease (P30) in complex with GRL-001 手法: X-RAY DIFFRACTION / 解像度: 1.27 Å PDB-6ogt: X-ray crystal structure of darunavir-resistant HIV-1 protease (P51) in complex with GRL-001 手法: X-RAY DIFFRACTION / 解像度: 1.21 Å PDB-6oyd: X-ray crystal structure of wild type HIV-1 protease in complex with GRL-004 手法: X-RAY DIFFRACTION / 解像度: 1.46 Å PDB-6oyr: X-ray crystal structure of wild type HIV-1 protease in complex with GRL-002 手法: X-RAY DIFFRACTION / 解像度: 1.54 Å
化合物	ChemComp-GOL: GLYCEROL / グリセロ-ル ChemComp-EDO: 1,2-ETHANEDIOL / エチレングリコ-ル ChemComp-JDV: (3S,3aR,5R,7aS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl [(2S,3R)-4-[{[2-(cyclopropylamino)-1,3-benzothiazol-6-yl]sulfonyl}(2-methylpropyl)amino]-1-(4-fluorophenyl)-3-hydroxybutan-2-yl]carbamate ChemComp-HOH: WATER ChemComp-MJD: (3S,3aR,5R,7aS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl {(2S,3R)-1-(3,5-difluorophenyl)-3-hydroxy-4-[(2-methylpropyl)({2-[(propan-2-yl)amino]-1,3-benzoxazol-6-yl}sulfonyl)amino]butan-2-yl}carbamate ChemComp-PEG: DI(HYDROXYETHYL)ETHER / ジエチレングリコ-ル ChemComp-SO4: SULFATE ION / 硫酸ジアニオン ChemComp-JDY: (3S,3aR,5R,7aS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl [(2S,3R)-4-[{[2-(cyclopropylamino)-1,3-benzothiazol-6-yl]sulfonyl}(2-methylpropyl)amino]-1-(3-fluorophenyl)-3-hydroxybutan-2-yl]carbamate ChemComp-NKA: (3S,3aR,5R,7aS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl {(2S,3R)-1-(4-fluorophenyl)-3-hydroxy-4-[(2-methylpropyl)({2-[(propan-2-yl)amino]-1,3-benzoxazol-6-yl}sulfonyl)amino]butan-2-yl}carbamate ChemComp-NJY: (3S,3aR,5R,7aS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl {(2S,3R)-1-(3-fluorophenyl)-3-hydroxy-4-[(2-methylpropyl)({2-[(propan-2-yl)amino]-1,3-benzoxazol-6-yl}sulfonyl)amino]butan-2-yl}carbamate
由来	human immunodeficiency virus 1 (ヒト免疫不全ウイルス)
キーワード	VIRAL PROTEIN/INHIBITOR / Inhibitor / VIRAL PROTEIN / VIRAL PROTEIN-INHIBITOR complex